Of the future technologies arising from the Human Genome Project, pharmacogenomics will probably be the first to have a widespread impact on the everyday practice of medicine. This technology offers great benefits but also presents some difficult ethical challenges. This paper explains what pharmacogenomics is and examines three of the issues that it raises: orphan populations, the use of ethnicity in drug trials, and potential obstacles to informed consent for genetic testing.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF03351409 | DOI Listing |
Publication Analysis
Top Keywords
ethics pharmacogenomics
4
pharmacogenomics future
4
future technologies
4
technologies arising
4
arising human
4
human genome
4
genome project
4
project pharmacogenomics
4
pharmacogenomics will
4
will widespread
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!